Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

AIM: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit from treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ESC Heart Fail
Hauptverfasser: Blaschke, Florian, Lacour, Philipp, Dang, Phi Long, Parwani, Abdul Shokor, Hohendanner, Felix, Walter, Thula, Klingel, Karin, Kühl, Uwe, Heinzel, Frank R., Sherif, Mohammad, Boldt, Leif‐Hendrik, Pieske, Burkert, Tschöpe, Carsten
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2021
Schlagworte:
Short Communications
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318471/
https://ncbi.nlm.nih.gov/pubmed/33932118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13340
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge